Delivery Order SPE2DB22D1002-SPE2DB24FKUX2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,167.61, is a delivery order for Dupixent 300 mg/2 ml pens. The award has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- This federal contract award, valued at $11,668.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period through December 5, 2023. The contract is a Firm Fixed Price Delivery Order, and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Dupixent 300 mg/2 ml pen, valued at $5,733.25. The award is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,304.72 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a ceiling value of $3,304.72 and a completion date of November 7, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) contract with a Ceiling Value of $54,684.68. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of Dupixent 300 mg/2 ml syringes. The contract has a firm fixed price and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,917.67 for the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 30, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,307.83 for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. The award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,936.76 delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of December 28, 2023. The contract is a firm-fixed-price delivery order and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,178.60 firm fixed-price contract covers the delivery of Dupixent 300 mg/2 ml pens for a period ending on January 30, 2024. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product, specifically Dupixent 300 mg/2 ml pen, with a ceiling value of $27,517.58 and a completion date of November 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKUX2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $5,597.01 from the Defense Logistics Agency (DLA) for the pharmaceutical product Dupixent 300 mg/2 ml pen. The award has an ultimate completion date of December 4, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a wide range of medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award does not have a set-aside designation, indicating it was procured through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 12/1/23 |